INmune Bio (INMB)

• Market cap: $53.4M
• 1 day: -6.07%
• 5 days: 6.35%
• 1 month: 32.24%
• 3 months: 0%
• 6 months: -74.62%
• Year to date: -59.23%
• 1 year: -58.73%
• 5 years: -78.08%
• 10 years: -74.84%
• Sector: Healthcare
• Industry: Biotechnology

About: INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.

Employees: 13